论文部分内容阅读
本院应用颅内血肿清除术联合神经节苷脂(GM1)治疗急性脑出血33例,取得很好疗效,报告如下。1对象与方法1.1对象2004年9月至2009年9月本院住院的脑出血患者,行颅内血肿清除术治疗者共66例,男48例,女18例;年龄45～85岁,平均(66.4±12.3)岁;均符合全国第四届脑血管病学术会议修订的诊断标准,并经头颅CT证实;有高血压病史者61例(92.42%)。随机分为2组。清除术+GM1组(联合组):33例,男24例,女9例;年龄46～85岁,平均
The hospital application of intracranial hematoma removal combined with ganglioside (GM1) in the treatment of acute cerebral hemorrhage in 33 cases, and achieved good results, the report is as follows. 1 Subjects and Methods 1.1 Subjects September 2004 to September 2009 hospitalized patients with cerebral hemorrhage, intracranial hematoma removal of a total of 66 patients, 48 males and 18 females; aged 45 to 85 years, mean (66.4 ± 12.3) years old respectively. All of them met the diagnostic criteria revised by the Fourth National Conference on Cerebrovascular Diseases and confirmed by skull CT. There were 61 cases (92.42%) with history of hypertension. Randomly divided into two groups. Removal + GM1 group (combined group): 33 cases, 24 males and 9 females; aged 46 to 85 years, mean